AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. APVO
  4. [ARS] Aptevo Therapeutics Inc SEC Filing

[ARS] Aptevo Therapeutics Inc SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Aptevo Therapeutics Inc

AG真人官方

ARS Filing - Aptevo Therapeutics Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Aptevo Therapeutics Inc (APVO)

Acceptance Date: 2025-07-03T16:15:12.000Z

Source:

Stock APVO logo
Aptevo Therapeutics Inc

NASDAQ:APVO

APVO Rankings

#9975 Ranked by Market Cap
N/A Ranked by Dividends

APVO Latest News

Aug 11, 2025
Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update
Jun 20, 2025
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Jun 20, 2025
Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers
Jun 18, 2025
Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Jun 18, 2025
Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML

APVO Latest SEC Filings

Aug 11, 2025
[10-Q] Aptevo Therapeutics Inc Quarterly Earnings Report
Aug 11, 2025
[8-K] Aptevo Therapeutics Inc Reports Material Event
Aug 8, 2025
[Form 4] Aptevo Therapeutics Inc Insider Trading Activity
Aug 8, 2025
[Form 4] Aptevo Therapeutics Inc Insider Trading Activity
Aug 8, 2025
[Form 4] Aptevo Therapeutics Inc Insider Trading Activity

APVO Stock Data

7.00M
2.86M
0%
0.05%
4.98%
Biotechnology
Pharmaceutical Preparations
United States
SEATTLE